PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 172 filers reported holding PORTOLA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $4,723,000 | -26.8% | 241,964 | -0.1% | 0.54% | -16.5% |
Q3 2018 | $6,453,000 | -51.5% | 242,302 | -31.2% | 0.65% | -52.5% |
Q2 2018 | $13,306,000 | +50.8% | 352,302 | +30.4% | 1.36% | +25.2% |
Q1 2018 | $8,826,000 | -14.1% | 270,248 | +28.0% | 1.09% | -21.7% |
Q4 2017 | $10,279,000 | -36.0% | 211,153 | -29.0% | 1.39% | -32.3% |
Q3 2017 | $16,069,000 | +158.2% | 297,400 | +168.4% | 2.05% | +129.4% |
Q2 2017 | $6,224,000 | +31.5% | 110,805 | -8.3% | 0.89% | +19.2% |
Q1 2017 | $4,734,000 | +74.6% | 120,805 | 0.0% | 0.75% | +44.2% |
Q4 2016 | $2,711,000 | -99.9% | 120,805 | 0.0% | 0.52% | +19.3% |
Q3 2016 | $2,743,482,000 | +110613.6% | 120,805 | +15.1% | 0.44% | -0.9% |
Q2 2016 | $2,478,000 | +15.7% | 105,000 | 0.0% | 0.44% | +3.5% |
Q1 2016 | $2,142,000 | -32.9% | 105,000 | +69.4% | 0.42% | -11.8% |
Q4 2015 | $3,190,000 | +5.4% | 62,000 | -12.7% | 0.48% | 0.0% |
Q3 2015 | $3,026,000 | -12.6% | 71,000 | -6.6% | 0.48% | +15.9% |
Q2 2015 | $3,462,000 | – | 76,000 | – | 0.42% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 1,220,672 | $52,025,000 | 8.00% |
Fernwood Investment Management, LLC | 190,011 | $8,098,000 | 7.10% |
Cormorant Asset Management, LP | 500,000 | $21,310,000 | 3.40% |
HARVEY CAPITAL MANAGEMENT INC | 157,930 | $6,730,000 | 2.69% |
Atika Capital Management LLC | 128,000 | $5,456,000 | 2.68% |
Redmile Group, LLC | 769,641 | $32,802,000 | 2.48% |
Temasek Holdings (Private) Ltd | 5,833,568 | $248,627,000 | 2.36% |
SECTORAL ASSET MANAGEMENT INC | 1,088,118 | $46,376,000 | 2.12% |
Eventide Asset Management | 479,900 | $20,453,000 | 1.19% |
BBT Capital Management, LLC | 200,000 | $8,524,000 | 0.79% |